The world’s biggest vaccine maker Serum Institute of India(SII),has applied tp local authorities to conduct a small domestic trial of Novavax Inc’s Covid-19 vaccine. This vaccine was found to be 89.3 percent effective in a UK trial.The Serum Institute of India (SII) is expecting to start trials soon.
According to the report by Reuters the Adar Poonawala, COO, Serum Institute of India has said “ “We have already applied to the drug controller’s office for the bridging trial, a few days ago,”.So they should also give that approval soon now.” After the results of 15,000 people aged 18 to 84, in Novavax’s UK trial,its expected the use of a vaccine in Britain and other countries
Uncovering the Molecular Secrets of Malaria’s Deadliest Strain: A New Research Project Malaria remains one…
Sunlight Can Cause Cancer: Prolonged exposure to sunlight and exposure to UV (ultraviolet) rays can…
https://youtu.be/mlBSCMO2NQg?si=UfC4C3WgtMZ9DhB4 Humans Are Swallowing Microplastics: A Hidden Environmental and Health Crisis In recent years, microplastics…
https://youtu.be/H_aiXVvX8Eg?si=vH4Arvq7pbpXERMF Obesity Drugs: A Comprehensive Guide to Weight Loss Solutions Obesity is one of the…
https://youtu.be/LZi8Jn0tAA8?si=bpMPudQxl1LUdgXN Cold Hands & Feet in Winter: Causes, Remedies, and Prevention Tips Winter can be…
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…